Researchers showed that R-spondin treatment reduces the growth of intestinal tumors, adenomas, in the early phase of colorectal cancer development. @helsinkiuni #HelsinkiHealth https://t.co/hKFCYFONqh

— Academic Medical Center Helsinki (@amchelsinki) September 23, 2020 06:19